58 related articles for article (PubMed ID: 8632425)
21. Enhancement of diltiazem bioavailability by traces of surfactants in rats after neomycin-induced malabsorption syndrome.
Wojdak H
Boll Chim Farm; 1998 Sep; 137(8):314-8. PubMed ID: 9835146
[TBL] [Abstract][Full Text] [Related]
22. Nasal administration of the calcium channel blocker diltiazem decreases food intake and attenuates weight gain in rats.
Amer A; Maher TJ
Pharmacol Biochem Behav; 2005 Oct; 82(2):379-87. PubMed ID: 16214208
[TBL] [Abstract][Full Text] [Related]
23. Deacetylation of diltiazem by several rabbit tissues.
Fraile LJ; Aramayona JJ; Bregante MA; García MA; Abadía AR
Pharm Res; 1996 Dec; 13(12):1875-80. PubMed ID: 8987088
[TBL] [Abstract][Full Text] [Related]
24. Transmembrane pH-gradient liposomes to treat cardiovascular drug intoxication.
Bertrand N; Bouvet C; Moreau P; Leroux JC
ACS Nano; 2010 Dec; 4(12):7552-8. PubMed ID: 21067150
[TBL] [Abstract][Full Text] [Related]
25. Interaction between prostaglandin E2 and l-cis-diltiazem, a specific blocker of cyclic nucleotide gated channels in bovine aortic endothelial cells.
Shalom R; Barki-Harrington L; Rimon G
Eur J Pharmacol; 2006 Aug; 543(1-3):8-13. PubMed ID: 16842773
[TBL] [Abstract][Full Text] [Related]
26. Effects of diltiazem or verapamil on calcium uptake and release from chicken skeletal muscle sarcoplasmic reticulum.
Paydar MJ; Pousti A; Farsam H; Amanlou M; Mehr SE; Dehpour AR
Can J Physiol Pharmacol; 2005 Nov; 83(11):967-75. PubMed ID: 16391705
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of the calcium-channel blocker diltiazem after a single intravenous dose in horses.
Schwarzwald CC; Sams RA; Bonagura JD
J Vet Pharmacol Ther; 2006 Jun; 29(3):165-71. PubMed ID: 16669860
[TBL] [Abstract][Full Text] [Related]
28. Optical resolution of a 1,5-benzothiazepine derivative, a synthetic intermediate of diltiazem, by preferential crystallization and diastereomeric salt formation.
Yamada S; Yoshioka R; Shibatani T
Chem Pharm Bull (Tokyo); 1997 Dec; 45(12):1922-7. PubMed ID: 9433761
[TBL] [Abstract][Full Text] [Related]
29. Comparison of diltiazem bioavailability from 3 marketed extended-release products for once-daily administration: implications of chronopharmacokinetics and dynamics.
Eradiri O; Midha KK
Int J Clin Pharmacol Ther; 1997 Sep; 35(9):369-73. PubMed ID: 9314089
[TBL] [Abstract][Full Text] [Related]
30. Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia.
Lim SH; Anantharaman V; Teo WS; Chan YH
Resuscitation; 2009 May; 80(5):523-8. PubMed ID: 19261367
[TBL] [Abstract][Full Text] [Related]
31. Anticonvulsant and sodium channel-blocking properties of novel 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide derivatives.
Benes J; Parada A; Figueiredo AA; Alves PC; Freitas AP; Learmonth DA; Cunha RA; Garrett J; Soares-da-Silva P
J Med Chem; 1999 Jul; 42(14):2582-7. PubMed ID: 10411478
[TBL] [Abstract][Full Text] [Related]
32. Analysis of diltiazem and its related substances by HPLC and HPLC/MS.
Quaglia MG; Donati E; Fanali S; Bossù E; Montinaro A; Buiarelli F
J Pharm Biomed Anal; 2005 Apr; 37(4):695-701. PubMed ID: 15797790
[TBL] [Abstract][Full Text] [Related]
33. Antiarrhythmic effects of LR-A/113 a new calcium antagonistic drug.
Stella L; de Novellis V; Vacca C; Guarino A; Cantoni V; Fici F; Rossi F
Res Commun Mol Pathol Pharmacol; 1996 Aug; 93(2):235-48. PubMed ID: 8884994
[TBL] [Abstract][Full Text] [Related]
34. The comparative effects of calcium channel blockers in an experimental colitis model in rats.
Zeytunlu M; Korkut M; Akgün E; Firat O; Aynaci M; Içöz G; Kiliç M; Ersin S; Ozütemiz O
Turk J Gastroenterol; 2004 Dec; 15(4):243-9. PubMed ID: 16249979
[TBL] [Abstract][Full Text] [Related]
35. Protective effect of diltiazem on cyanide-induced neurotoxicity in Wistar strain rats.
Mathangi DC; Namasivayam A
Food Chem Toxicol; 2004 Apr; 42(4):605-8. PubMed ID: 15019184
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of some 4-[3' or 4'-(4H- 4-oxo-1-benzopyran-2-yl)phenyl]-1,4-dihydropyridine derivatives as potential calcium channel antagonists.
Tunçbilek M; Ertan R
Pharmazie; 1999 Apr; 54(4):255-9. PubMed ID: 10234737
[TBL] [Abstract][Full Text] [Related]
37. Differential effect of two calcium channel blockers--nifedipine and diltiazem--on atherogenesis in hypercholesterolemic hamster.
Raicu M; Pojoga L; Simionescu N; Simionescu M
J Submicrosc Cytol Pathol; 1996 Apr; 28(2):265-75. PubMed ID: 8964051
[TBL] [Abstract][Full Text] [Related]
38. First-pass metabolism of diltiazem in anesthetized rabbits: role of extrahepatic organs.
Lefebvre M; Homsy W; Caillé G; du Souich P
Pharm Res; 1996 Jan; 13(1):124-8. PubMed ID: 8668661
[TBL] [Abstract][Full Text] [Related]
39. Discovery of novel and cardioselective diltiazem-like calcium channel blockers via virtual screening.
Carosati E; Budriesi R; Ioan P; Ugenti MP; Frosini M; Fusi F; Corda G; Cosimelli B; Spinelli D; Chiarini A; Cruciani G
J Med Chem; 2008 Sep; 51(18):5552-65. PubMed ID: 18754582
[TBL] [Abstract][Full Text] [Related]
40. Enhanced diltiazem deacetylase activity in pre-term and full-term rabbits compared with adult rabbits.
Fraile LJ; Aramayona JJ; Bregante MA; García MA; Solans C
Biol Neonate; 1997; 72(1):51-61. PubMed ID: 9313835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
